Utilization review software tracks the authorizations a payer grants for a client’s care, flags when approved days or units are about to run out, and generates the reports a reviewer needs to approve a continued stay. For behavioral health and addiction treatment programs, that job only works if it ties back to something objective: the ASAM criteria that justify the level of care, the documentation trail a CARF or Joint Commission surveyor expects to see, and the consent rules that govern what you can actually hand a payer under 42 CFR Part 2. A tool that just counts approved hours misses most of what makes utilization review hard in this field, and the gap usually surfaces at the worst possible time: a denied continued-stay request that a program has no quick way to appeal, or a surveyor question about level-of-care justification that nobody can answer from the software alone. Here is what the category should do, where the standard vendor page falls short, and where BestNotes fits.
What Does Utilization Review Software Actually Do?
At its core, it replaces a spreadsheet or a stack of sticky notes with a system that tracks every authorization a payer has granted: the level of care, the number of approved days or units, the review date, and who at your program is responsible for the next submission.
When that tracking works well, a case manager gets a heads-up several days before an authorization expires instead of finding out the day a claim gets denied. The software should also pull directly from the clinical record, since a utilization reviewer at the payer’s end wants to see progress notes, updated symptom severity, and a clear rationale for why the client still needs this level of care, not a separate summary written from memory. Good utilization review software connects three groups who often work from different systems: the clinical team writing the notes, the utilization review staff preparing the submission, and billing, who needs to know the moment an authorization lapses so a claim doesn’t go out for a service that was never approved. When those three groups share one record instead of three disconnected ones, a program catches an expiring authorization before it becomes a denied claim instead of after.
How Should It Tie Authorizations to ASAM Level-of-Care Criteria?
A payer doesn’t approve a level of care because a clinician thinks it is appropriate. They approve it because the documentation shows the client meets specific criteria, and for addiction treatment, that almost always means the ASAM criteria.
The ASAM 4th edition organizes that justification across six dimensions: intoxication and withdrawal potential, biomedical conditions, psychiatric and cognitive conditions, readiness to change, relapse and continued use potential, and the recovery environment. A utilization review submission that walks through where a client scores on each of those dimensions gives a reviewer something concrete to approve, while a submission that just states “client continues to need residential treatment” gives them nothing to work with and invites a denial or a request for more information. Software built for this should let a case manager pull the client’s current ASAM ratings directly into the authorization request rather than retyping them from a separate assessment, and it should flag when a dimension score hasn’t been updated recently enough to support the level of care being requested. None of the standard utilization review tools on the market connect to ASAM scoring at all. They track the authorization once a payer approves it, but they offer no help building the clinical case that gets it approved in the first place, which leaves that part of the job exactly as manual as it was before the software existed.
How Does 42 CFR Part 2 Change What You Can Share With a Reviewer?
Utilization review means sharing clinical detail with someone outside your program, and for a client in substance use disorder treatment, that puts you squarely inside 42 CFR Part 2’s consent rules.
Historically, Part 2 required a fresh, specific consent for each disclosure to a payer, which meant a case manager submitting monthly continued-stay reviews needed a new authorization on file every time. A 2024 final rule changed that: it now allows a single consent to cover treatment, payment, and health care operations disclosures together, including the ones utilization review depends on, so a program doesn’t need to chase down a new signature every review cycle. That change became enforceable on February 16, 2026, when HHS’s Office for Civil Rights began civil enforcement of the updated rule, with penalties that now follow HIPAA’s structure rather than Part 2’s older, narrower ones. The consent change doesn’t remove the restriction, though. A payer or reviewer who receives records under that single consent is still bound by rules on how they can use or redisclose them, and your utilization review software should make it obvious which consent covers a given disclosure and when it expires. A tool that can’t answer that question when a surveyor or a compliance officer asks it is a liability wearing the shape of a convenience.
What Do CARF and Joint Commission Surveyors Expect to See?
Neither CARF nor the Joint Commission tells you which utilization review software to buy, but both expect a program to prove that every level-of-care decision and every extension of a client’s stay was tied to documented clinical criteria, not just a payer’s yes.
That means a surveyor pulling a chart at random should be able to trace a straight line from the client’s presenting symptoms, through the clinical assessment, to the level of care that was requested and the criteria cited to support it, and finally to whatever the payer approved or denied. A program that keeps authorization numbers in a spreadsheet disconnected from the chart usually can’t produce that trail quickly, if at all, and a scramble during a survey is its own kind of red flag. Programs preparing for either accreditation body can see how this fits into the rest of the documentation set our CARF compliance software selection criteria piece covers, and our Joint Commission EHR documentation checklist walks through the broader survey-readiness picture beyond utilization review specifically.
How Often Should Continued-Stay Reviews Actually Happen?
The review schedule depends on the level of care, and getting it wrong in either direction costs a program money or credibility.
Residential and inpatient programs typically face a utilization review cycle every 7 to 14 days, since the cost and intensity of that level of care draws closer payer scrutiny. Intensive outpatient and partial hospitalization programs usually see a longer cycle, closer to every 30 days, often aligned with the standard treatment plan review rather than run as a separate process. A program that treats every level of care on the same review timeline either wastes staff time submitting residential-frequency reviews for an IOP client who doesn’t need them, or misses a residential review window because the system was not built to distinguish between the two. Utilization review software should let a program set that cadence by level of care once, then generate the reminder automatically instead of relying on someone remembering which client is on which schedule.
What Should You Check Before Buying Utilization Review Software?
The features worth prioritizing are the ones that connect utilization review to the rest of the clinical record, not the ones that make the authorization list look tidier on screen.
Start by asking whether the tool pulls ASAM scores and clinical notes directly into an authorization submission, or whether staff still have to copy that information over by hand. Check how it handles 42 CFR Part 2 consent tracking specifically, since general HIPAA consent tracking doesn’t automatically cover Part 2’s separate rules, and ask to see exactly what a compliance report looks like when someone needs to prove which consent authorized a given disclosure. Confirm it lets you set review cadence by level of care rather than applying one schedule to every client, and ask what happens when an authorization is about to lapse: does the system alert a case manager days ahead, or only after the fact when a claim already went out unpaid. Ask, too, whether the software can show you which payers deny continued-stay requests most often and why, since that kind of pattern is nearly impossible to spot by hand once a program is managing more than a handful of active authorizations at once, and knowing it lets a program build a stronger case before the next submission instead of reacting to the same denial reason over and over. Look closely at whether pricing is published anywhere or whether every vendor in the category routes you to a sales call before naming a number, since that alone tells you something about how the rest of the buying process will go. And ask whether the software lives on the same platform as your clinical documentation and billing, or as a separate system that needs its own login and its own manual sync, since a utilization review tool bolted onto the side of an unrelated EHR tends to fall out of date the first time someone forgets to update both places.
How Does BestNotes Handle Utilization Review?
BestNotes includes Utilization Review as one of the documented note types inside its Clinical Profile, alongside treatment plans, progress notes, and discharge summaries, so a utilization review entry sits in the same record as the assessment and progress notes a reviewer would want to see, not in a separate tool.
Because it runs on the same platform as the rest of a program’s behavioral health EHR, a utilization review note can reference the same ASAM ratings and consent records already on file instead of asking staff to re-enter them somewhere else. Programs working specifically in addiction treatment can see how utilization review fits alongside consent and level-of-care documentation on our addiction treatment EHR page, and our piece on ASAM and level-of-care documentation covers how the underlying clinical scoring gets built before it ever reaches a utilization review submission. BestNotes publishes its pricing directly rather than requiring a sales call to learn it: $59 per user for the first 10 users, dropping to $25 per user from 11 to 100, and $13 per user beyond that, plus a one-time $100 setup fee.
Frequently Asked Questions
What does utilization review software actually track? Authorizations a payer has granted, including the level of care, approved days or units, review dates, and who on staff owns the next submission, ideally pulled from the same record as the clinical documentation rather than kept separately.
Is utilization review the same as prior authorization? Not quite. Prior authorization happens before treatment starts, while utilization review is the ongoing process of justifying continued care, often called concurrent review, at intervals that vary by level of care.
Does utilization review software need to connect to ASAM scoring? It should, at least for addiction treatment programs, since a submission built around specific ASAM dimension scores gives a payer something concrete to approve instead of a general clinical impression.
How does 42 CFR Part 2 affect what a utilization reviewer can see? A single consent can now cover disclosures to a payer for treatment, payment, and health care operations together, following the rule change enforceable since February 16, 2026, but the payer receiving that record is still restricted in how it can use or redisclose it.
How often should a continued-stay review happen? Residential and inpatient levels of care typically need a review every 7 to 14 days, while IOP and PHP levels usually run closer to a 30-day cycle tied to the treatment plan review.
Do CARF and Joint Commission require specific utilization review software? No. Neither body certifies a particular product. Both expect a program to produce documentation showing that level-of-care and length-of-stay decisions were tied to objective clinical criteria, whichever system that documentation lives in.
What happens when a continued-stay request gets denied? Most payers allow a peer-to-peer review, where a program clinician talks directly with the payer’s medical reviewer to make the case for continued care, and having the ASAM scoring and progress notes already organized in one place makes that conversation far shorter than pulling the file together on the spot.
Can utilization review software actually reduce claim denials? It can help by catching an expiring authorization before a claim goes out against it and by surfacing denial patterns by payer over time, though no software eliminates denials outright since payers still make their own medical necessity determinations case by case.
Choosing Utilization Review Software That Holds Up Under Review
The right utilization review software does more than count down approved days. It ties every authorization request back to the ASAM criteria that actually justify the level of care, keeps 42 CFR Part 2 consent tracking distinct from general HIPAA compliance, and produces the kind of documented trail a CARF or Joint Commission surveyor wants to see without anyone scrambling to reconstruct it during a survey. It also respects that residential, IOP, and PHP programs run on different review clocks, and it shouldn’t force every client through the same schedule. A tool that only tracks the authorization number misses the part of the job that actually determines whether the authorization gets approved in the first place, and that gap tends to show up at the worst possible time, either during a payer audit or an accreditation survey.
About the Author
Nicole Hovey is a marketing and communications leader at BestNotes, where she helps behavioral health and addiction treatment organizations find tools that streamline workflows, strengthen outcomes, and support clinical excellence. With a background in behavioral health program operations, digital strategy, and customer engagement, Nicole brings a unique blend of industry insight and practical experience to her writing.
At BestNotes, Nicole develops educational content, webinar programs, and product-focused resources that empower providers to stay ahead of regulatory changes, leverage emerging technologies, and deliver more efficient, data-driven care. She is especially passionate about helping organizations understand how EHRs, AI, and outcomes tracking work together to improve client experiences and reduce clinician burnout.
